The Twitter application is seen on a digital device, Monday, April 25, 2022, in San Diego. (AP Photo/Gregory Bull, File)
After a three-year hiatus, Twitter is set to reverse course on its ban of political ads.
In 2019, Twitter and then-CEO Jack Dorsey moved to ban cause-based ads in an effort, in part, to reduce the spread of misinformation and paid advertising for smear campaigns but the bird app could be reversing course under Elon Musk's leadership.
Musk is a self-described advocate for free speech and the move comes as Twitter struggles to become profitable. In 2018, when political ads had a green light, they accounted for less than $3 million of total spending during the U.S. midterm elections. Facebook also enacted limits on political and social issue advertising at the time but reversed its decision in 2021.
Last November, Twitter went through some turmoil when notable companies like Chipotle, General Mills, Pfizer, United Airlines, and others, halted advertising on the platform after Musk's takeover.
Intel CEO Lip-Bu Tan says he’s “always operated within the highest legal and ethical standards” after coming under pressure following President Donald Trump’s call for him to resign.
Millions of Americans saving for retirement through 401(k) accounts could have the option of putting their money in higher-risk private equity and cryptocurrency investments.
A new federal rule would make it easier for companies to use drones over longer distances out of sight of the operator without having to go through a cumbersome waiver process.
President Donald Trump has signed the GENIUS Act into law, setting new regulations for stablecoins, a type of cryptocurrency tied to assets like the U.S. dollar.
A top Federal Reserve official said late Thursday that the central bank should cut its key interest rate later this month, carving out a different view than that of Chair Jerome Powell
Stocks fell on Wall Street as the Trump administration stepped up pressure on trading partners to make deals before punishing tariffs imposed by the U.S. take effect.
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
